首页 > 最新文献

Clinical medicine. Cardiology最新文献

英文 中文
The threshold of admission glycemia as a predictor of adverse events in diabetic and non-diabetic patients with acute coronary syndrome. 作为急性冠状动脉综合征糖尿病和非糖尿病患者不良事件预测指标的入院血糖阈值。
Pub Date : 2009-04-01 DOI: 10.4137/cmc.s2289
Taysir S Garadah, Salah Kassab, Qasim M Al-Shboul, Abdulhai Alawadi

Unlabelled: Recent studies indicated a high prevalence of hyperglycemia in non-diabetic patients presenting with acute coronary syndrome (ACS). However, the threshold of admission glucose (AG) as a predictor of adverse events in ACS is unclear.

Objective: The aim of this study was to assess the threshold of admission glucose (AG) as a predictor of adverse events including Major Acute Cardiac Events (MACE) and mortality, during the first week of admitting patients presenting with ACS.

Material and methods: The data of 551 patients with ACS were extracted and evaluated. Patients were stratified according to their blood glucose on admission into three groups: group 1: 7 mmol/L and <15 mmol/L (n = 178, 32.3%) and group 3: >/=15 mmol/L (n = 173, 31.4%). Stress hyperglycemia was arbitrarily defined as AG levels > 7 mmol/L (group 2 and 3). Patients with ACS were sub-divided into two groups: patients with unstable angina (UA, n = 285) and those with ST segment elevation myocardial Infarction (STEMI, n = 266) and data were analyzed separately using multiple regression analysis.

Results: The mean age of patients was 59.7 +/- 14.8 years and 63% were males. The overall mortality in the population was 8.5% (5.4% in STEMI and 3.1% in UA) patients. In STEMI patients, the odds ratio of stress hyperglycemia as predictor of mortality in group 3 compared with group 1 was 3.3 (CI 0.99-10.98, P < 0.05), while in group 2 compared with group 1 was 2.4 (CI: 0.75-8.07, P = 0.065) after adjustment for age and sex. Similarly, in UA patients, the odds ratio of stress hyperglycemia in group 3 compared with group 1 was 2.7 (CI 0.37-18.98, P < 0.05), while in group 2 compared with group 1 was 2.4 (CI: 0.4-15.2, P = 0.344) after adjustment for age and sex. The incidence of more than 2 MACE in both STEMI and UA patients was higher in group 3 compared with the other two groups. Regression analysis showed that history of DM, high level of LDL cholesterol, high level of HbA1c, and anterior infarction were significant predictors of adverse events while other risk factors such as BMI, history of hypertension and smoking were of no significance.

Conclusion: This study indicates that the stress hyperglycemia on admission is a powerful predictor of increased major adverse events and hospital mortality in patients with acute coronary syndrome.

无标签:最近的研究表明,非糖尿病急性冠状动脉综合征(ACS)患者中高血糖的发病率很高。然而,入院血糖(AG)作为 ACS 不良事件预测因子的阈值尚不明确:本研究旨在评估急性冠脉综合征患者入院第一周的入院血糖(AG)作为不良事件(包括主要急性心脏事件(MACE)和死亡率)预测因子的阈值:提取并评估了 551 例 ACS 患者的数据。根据入院时的血糖将患者分为三组:第一组:7 mmol/L 和 /=15 mmol/L(n = 173,31.4%)。应激性高血糖任意定义为 AG 水平大于 7 mmol/L(第 2 组和第 3 组)。ACS患者被细分为两组:不稳定型心绞痛患者(UA,n = 285)和ST段抬高型心肌梗死患者(STEMI,n = 266),并分别使用多元回归分析法对数据进行分析:患者平均年龄为 59.7 +/- 14.8 岁,63% 为男性。总死亡率为 8.5%(STEMI 患者为 5.4%,UA 患者为 3.1%)。在 STEMI 患者中,经年龄和性别调整后,第 3 组与第 1 组相比,应激性高血糖预测死亡率的几率比为 3.3(CI 0.99-10.98,P < 0.05),而第 2 组与第 1 组相比,应激性高血糖预测死亡率的几率比为 2.4(CI:0.75-8.07,P = 0.065)。同样,在 UA 患者中,经年龄和性别调整后,第 3 组与第 1 组相比,应激性高血糖的几率比为 2.7(CI:0.37-18.98,P<0.05),而第 2 组与第 1 组相比,应激性高血糖的几率比为 2.4(CI:0.4-15.2,P=0.344)。与其他两组相比,第 3 组 STEMI 和 UA 患者发生 2 次以上 MACE 的几率更高。回归分析表明,糖尿病史、高水平低密度脂蛋白胆固醇、高水平 HbA1c 和前梗死是不良事件的重要预测因素,而其他风险因素如体重指数、高血压史和吸烟均无显著意义:本研究表明,入院时的应激性高血糖是急性冠状动脉综合征患者主要不良事件和住院死亡率增加的有力预测因素。
{"title":"The threshold of admission glycemia as a predictor of adverse events in diabetic and non-diabetic patients with acute coronary syndrome.","authors":"Taysir S Garadah, Salah Kassab, Qasim M Al-Shboul, Abdulhai Alawadi","doi":"10.4137/cmc.s2289","DOIUrl":"10.4137/cmc.s2289","url":null,"abstract":"<p><strong>Unlabelled: </strong>Recent studies indicated a high prevalence of hyperglycemia in non-diabetic patients presenting with acute coronary syndrome (ACS). However, the threshold of admission glucose (AG) as a predictor of adverse events in ACS is unclear.</p><p><strong>Objective: </strong>The aim of this study was to assess the threshold of admission glucose (AG) as a predictor of adverse events including Major Acute Cardiac Events (MACE) and mortality, during the first week of admitting patients presenting with ACS.</p><p><strong>Material and methods: </strong>The data of 551 patients with ACS were extracted and evaluated. Patients were stratified according to their blood glucose on admission into three groups: group 1: </=7 mmol/L (n = 200, 36.3%) and group 2: >7 mmol/L and <15 mmol/L (n = 178, 32.3%) and group 3: >/=15 mmol/L (n = 173, 31.4%). Stress hyperglycemia was arbitrarily defined as AG levels > 7 mmol/L (group 2 and 3). Patients with ACS were sub-divided into two groups: patients with unstable angina (UA, n = 285) and those with ST segment elevation myocardial Infarction (STEMI, n = 266) and data were analyzed separately using multiple regression analysis.</p><p><strong>Results: </strong>The mean age of patients was 59.7 +/- 14.8 years and 63% were males. The overall mortality in the population was 8.5% (5.4% in STEMI and 3.1% in UA) patients. In STEMI patients, the odds ratio of stress hyperglycemia as predictor of mortality in group 3 compared with group 1 was 3.3 (CI 0.99-10.98, P < 0.05), while in group 2 compared with group 1 was 2.4 (CI: 0.75-8.07, P = 0.065) after adjustment for age and sex. Similarly, in UA patients, the odds ratio of stress hyperglycemia in group 3 compared with group 1 was 2.7 (CI 0.37-18.98, P < 0.05), while in group 2 compared with group 1 was 2.4 (CI: 0.4-15.2, P = 0.344) after adjustment for age and sex. The incidence of more than 2 MACE in both STEMI and UA patients was higher in group 3 compared with the other two groups. Regression analysis showed that history of DM, high level of LDL cholesterol, high level of HbA1c, and anterior infarction were significant predictors of adverse events while other risk factors such as BMI, history of hypertension and smoking were of no significance.</p><p><strong>Conclusion: </strong>This study indicates that the stress hyperglycemia on admission is a powerful predictor of increased major adverse events and hospital mortality in patients with acute coronary syndrome.</p>","PeriodicalId":88450,"journal":{"name":"Clinical medicine. Cardiology","volume":"3 ","pages":"29-36"},"PeriodicalIF":0.0,"publicationDate":"2009-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872579/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29019921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Age-related alteration of risk profile, inflammatory response, and angiographic findings in patients with acute coronary syndrome. 急性冠状动脉综合征患者的年龄相关性风险谱、炎症反应和血管造影结果的改变
Pub Date : 2009-02-18 DOI: 10.4137/cmc.s2118
Hala Mahfouz Badran, Mohamed Fahmy Elnoamany, Tarek Salah Khalil, Mostafa Mohamed Ezz Eldin

Background: Coronary artery disease (CAD) is a major public health problem which in turn imposes a significant burden on health care systems because of high morbidity and mortality. Although the multifactorial etiology of CAD increases with age, but in recent years, the incidence is increasing among younger age groups.

Objectives: In this study we aimed to evaluate the effect of age on risk profile, inflammatory response and the angiographic findings in patients with ACS.

Patients and methods: The study comprised 253 ACS patients. Seventy six (30%) with UA, 56 (22%) with NSTEMI and 121(48%) with STEMI diagnosis. The value of Hs-CRP, lipid profile, cardiac enzymes, risk factors, EF% and angiographic score were analyzed and compared in different age groups.

Results: Group 1 (n = 68) with age <45 years, group II (n = 110) with age >/=45-<65 years and group III (n = 75) >/=65 years. Group I had more prevalence of male sex, smoking, family history, hypertriglyceridemia and low levels of HDL (P < 0.01), higher incidence of STEMI (P < 0.01) and lower prevalence of UA (P < 0.01). Diabetes mellitus, hypertension, and female gender were more common in older groups. Hs-CRP was significantly lower in the young age (group I). Group I showed a preponderance of single-vessel disease, lower coronary atherosclerotic score and prevalent left anterior descending artery (LAD) involvement compared with older age groups. Hs-CRP was positively correlated to severity of CAD only in older groups. Stepwise multiple regression analysis showed that age, male gender, cardiac enzymes and EF% were common predictors of multivessel disease. Smoking was independent predictor in young patients <45 years while diabetes and Hs-CRP was the key predictor in older patient groups.

Conclusion: Young patients with ACS had different clinical, angiographic and biochemical profile. Hs-CRP peak concentration did not correlate with angiographic findings in young patients that could be attributed to different risk profile and discrete underlying mechanism.

背景:冠状动脉疾病(CAD)是一个重大的公共卫生问题,由于其高发病率和死亡率,给卫生保健系统带来了沉重的负担。虽然冠心病的多因素病因随着年龄的增长而增加,但近年来,发病率在年轻年龄组中呈上升趋势。目的:在这项研究中,我们旨在评估年龄对ACS患者的风险概况、炎症反应和血管造影结果的影响。患者和方法:研究纳入253例ACS患者。76例(30%)为UA, 56例(22%)为NSTEMI, 121例(48%)为STEMI诊断。分析比较不同年龄组Hs-CRP、血脂、心酶、危险因素、EF%及血管造影评分。结果:第一组(n = 68),年龄45 ~ 65岁。ⅰ组患者男性、吸烟、家族史、高甘油三酯血症、低HDL患病率较高(P < 0.01), STEMI发生率较高(P < 0.01), UA患病率较低(P < 0.01)。糖尿病、高血压和女性在老年人群中更为常见。Hs-CRP在年轻组(I组)明显降低。与老年组相比,I组表现出单血管疾病的优势,冠状动脉粥样硬化评分较低,左前降支(LAD)普遍受累。Hs-CRP与冠心病严重程度仅在老年组呈正相关。逐步多元回归分析显示,年龄、男性性别、心脏酶和EF%是多血管疾病的常见预测因子。结论:年轻ACS患者具有不同的临床、血管造影和生化特征。Hs-CRP峰值浓度与年轻患者的血管造影结果无关,这可能归因于不同的风险概况和离散的潜在机制。
{"title":"Age-related alteration of risk profile, inflammatory response, and angiographic findings in patients with acute coronary syndrome.","authors":"Hala Mahfouz Badran,&nbsp;Mohamed Fahmy Elnoamany,&nbsp;Tarek Salah Khalil,&nbsp;Mostafa Mohamed Ezz Eldin","doi":"10.4137/cmc.s2118","DOIUrl":"https://doi.org/10.4137/cmc.s2118","url":null,"abstract":"<p><strong>Background: </strong>Coronary artery disease (CAD) is a major public health problem which in turn imposes a significant burden on health care systems because of high morbidity and mortality. Although the multifactorial etiology of CAD increases with age, but in recent years, the incidence is increasing among younger age groups.</p><p><strong>Objectives: </strong>In this study we aimed to evaluate the effect of age on risk profile, inflammatory response and the angiographic findings in patients with ACS.</p><p><strong>Patients and methods: </strong>The study comprised 253 ACS patients. Seventy six (30%) with UA, 56 (22%) with NSTEMI and 121(48%) with STEMI diagnosis. The value of Hs-CRP, lipid profile, cardiac enzymes, risk factors, EF% and angiographic score were analyzed and compared in different age groups.</p><p><strong>Results: </strong>Group 1 (n = 68) with age <45 years, group II (n = 110) with age >/=45-<65 years and group III (n = 75) >/=65 years. Group I had more prevalence of male sex, smoking, family history, hypertriglyceridemia and low levels of HDL (P < 0.01), higher incidence of STEMI (P < 0.01) and lower prevalence of UA (P < 0.01). Diabetes mellitus, hypertension, and female gender were more common in older groups. Hs-CRP was significantly lower in the young age (group I). Group I showed a preponderance of single-vessel disease, lower coronary atherosclerotic score and prevalent left anterior descending artery (LAD) involvement compared with older age groups. Hs-CRP was positively correlated to severity of CAD only in older groups. Stepwise multiple regression analysis showed that age, male gender, cardiac enzymes and EF% were common predictors of multivessel disease. Smoking was independent predictor in young patients <45 years while diabetes and Hs-CRP was the key predictor in older patient groups.</p><p><strong>Conclusion: </strong>Young patients with ACS had different clinical, angiographic and biochemical profile. Hs-CRP peak concentration did not correlate with angiographic findings in young patients that could be attributed to different risk profile and discrete underlying mechanism.</p>","PeriodicalId":88450,"journal":{"name":"Clinical medicine. Cardiology","volume":"3 ","pages":"15-28"},"PeriodicalIF":0.0,"publicationDate":"2009-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4137/cmc.s2118","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29019920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 42
Initial cardiac rhythm correlated to emergency department survival. 初始心律与急诊存活率相关。
Pub Date : 2009-02-09 DOI: 10.4137/cmc.s695
Rade B Vukmir

Background: This study attempted to correlate the initial cardiac rhythm and survival from prehospital cardiac arrest, as a secondary end-point.

Methods: Prospective, randomized, double-blinded clinical intervention trial where bicarbonate was administered to 874 prehospital cardiopulmonary arrest patients in prehospital urban, suburban, and rural emergency medical service environments.

Results: This group's manifested an overall survival rate of 13.9% (110 of 793) of prehospital cardiac arrest patients. The most common presenting arrhythmia was ventricular fibrillation (VF) (45.0%), asystole (ASY) (34.4%), and pulseless electrical activity (PEA) (15.7%). Less commonly found were normal sinus rhythm (NSR) (1.8%), other (1.8%), ventricular tachycardia (VT) (0.6%), and atrioventricular block (AVB) (0.5%) as prearrest rhythms. The best survival was noted in those with a presenting rhythm of AVB (57.1%), VT (33.3%), VF (15.7%), NSR (14.3%), PEA (11.2%), and ASY (11.1%) (p = 0.02). However, there was no correlation between the final cardiac rhythm and outcome, other than an obvious end-of-life rhythm.

Conclusion: The most common presenting arrhythmia was VF (45%), while survival is greatest in those presenting with AVB (57.1%).

背景:本研究试图将初始心律与院前心脏骤停的存活率作为次要终点进行关联。方法:前瞻性、随机、双盲临床干预试验,对874名院前城市、郊区和农村急救医疗服务环境中的院前心肺骤停患者施用碳酸氢盐。结果:该组的院前心脏骤停患者的总生存率为13.9%(110/793)。最常见的心律失常表现为心室颤动(VF)(45.0%)、心搏停止(ASY)(34.4%)和无脉冲电活动(PEA)(15.7%)。不常见的心律是正常窦性心律(NSR)(1.8%)、其他心律(1.8%),室性心动过速(VT)(0.6%)和房室传导阻滞(AVB)(0.5%)。存活率最高的是出现AVB(57.1%)、VT(33.3%)、VF(15.7%)、NSR(14.3%)、PEA(11.2%)和ASY(11.1%)节律的患者(p=0.02)。然而,除了明显的临终节律外,最终心律与结果之间没有相关性。结论:最常见的心律失常表现为VF(45%),而AVB患者的存活率最高(57.1%)。
{"title":"Initial cardiac rhythm correlated to emergency department survival.","authors":"Rade B Vukmir","doi":"10.4137/cmc.s695","DOIUrl":"10.4137/cmc.s695","url":null,"abstract":"<p><strong>Background: </strong>This study attempted to correlate the initial cardiac rhythm and survival from prehospital cardiac arrest, as a secondary end-point.</p><p><strong>Methods: </strong>Prospective, randomized, double-blinded clinical intervention trial where bicarbonate was administered to 874 prehospital cardiopulmonary arrest patients in prehospital urban, suburban, and rural emergency medical service environments.</p><p><strong>Results: </strong>This group's manifested an overall survival rate of 13.9% (110 of 793) of prehospital cardiac arrest patients. The most common presenting arrhythmia was ventricular fibrillation (VF) (45.0%), asystole (ASY) (34.4%), and pulseless electrical activity (PEA) (15.7%). Less commonly found were normal sinus rhythm (NSR) (1.8%), other (1.8%), ventricular tachycardia (VT) (0.6%), and atrioventricular block (AVB) (0.5%) as prearrest rhythms. The best survival was noted in those with a presenting rhythm of AVB (57.1%), VT (33.3%), VF (15.7%), NSR (14.3%), PEA (11.2%), and ASY (11.1%) (p = 0.02). However, there was no correlation between the final cardiac rhythm and outcome, other than an obvious end-of-life rhythm.</p><p><strong>Conclusion: </strong>The most common presenting arrhythmia was VF (45%), while survival is greatest in those presenting with AVB (57.1%).</p>","PeriodicalId":88450,"journal":{"name":"Clinical medicine. Cardiology","volume":"3 ","pages":"9-14"},"PeriodicalIF":0.0,"publicationDate":"2009-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4137/cmc.s695","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29019919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Antiplatelet Resistance—Does it Exist and How to Measure it? 抗血小板抵抗——是否存在及如何测量?
Pub Date : 2009-01-01 DOI: 10.4137/CMC.S2159
S. Saraf, I. Bensalha, Diana A Gorog
Aspirin and clopidogrel are the most commonly used antiplatelet agents in patients with coronary artery disease. The existence of resistance to these agents has been a controversial issue and new drugs are being developed to overcome this problem. Laboratory tests, which can identify resistance and correlate this with clinical outcome, are being studied in order to identify patients at risk of future thrombotic events. We discuss the evidence for the existence of antiplatelet resistance—both in the laboratory and in the clinical setting. So far, platelet aggregometry has been considered the gold standard test, but is very operator dependant, time consuming, and has shown little correlation with other available tests of antiplatelet resistance. We discuss the available tests of platelet function, their limitations, and evidence for their use. A simple, rapid, near-patient test, which is affordable and useful in the clinical (not just laboratory) setting, could allow risk stratification of patients and individualization of antiplatelet medication to improve outcome.
阿司匹林和氯吡格雷是冠状动脉疾病患者最常用的抗血小板药物。对这些药物的耐药性一直是一个有争议的问题,正在开发新的药物来克服这个问题。目前正在研究能够确定耐药性并将其与临床结果相关联的实验室检测,以确定未来有血栓事件风险的患者。我们讨论抗血小板抵抗存在的证据-在实验室和在临床设置。到目前为止,血小板聚集被认为是金标准测试,但它非常依赖于操作人员,耗时,并且与其他可用的抗血小板耐药测试的相关性很小。我们讨论了现有的血小板功能测试,它们的局限性,以及它们使用的证据。一种简单、快速、接近患者的测试,在临床(不仅仅是实验室)环境中是负担得起的和有用的,可以允许患者的风险分层和抗血小板药物的个体化来改善结果。
{"title":"Antiplatelet Resistance—Does it Exist and How to Measure it?","authors":"S. Saraf, I. Bensalha, Diana A Gorog","doi":"10.4137/CMC.S2159","DOIUrl":"https://doi.org/10.4137/CMC.S2159","url":null,"abstract":"Aspirin and clopidogrel are the most commonly used antiplatelet agents in patients with coronary artery disease. The existence of resistance to these agents has been a controversial issue and new drugs are being developed to overcome this problem. Laboratory tests, which can identify resistance and correlate this with clinical outcome, are being studied in order to identify patients at risk of future thrombotic events. We discuss the evidence for the existence of antiplatelet resistance—both in the laboratory and in the clinical setting. So far, platelet aggregometry has been considered the gold standard test, but is very operator dependant, time consuming, and has shown little correlation with other available tests of antiplatelet resistance. We discuss the available tests of platelet function, their limitations, and evidence for their use. A simple, rapid, near-patient test, which is affordable and useful in the clinical (not just laboratory) setting, could allow risk stratification of patients and individualization of antiplatelet medication to improve outcome.","PeriodicalId":88450,"journal":{"name":"Clinical medicine. Cardiology","volume":"43 1","pages":"77 - 91"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86521439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
Relationship between the plasma concentration of C-reactive protein and severity of peripheral arterial disease. 血浆中 C 反应蛋白浓度与外周动脉疾病严重程度之间的关系。
Pub Date : 2008-12-23 DOI: 10.4137/cmc.s1062
Joaquin De Haro, Francisco Acin, Francisco Jose Medina, Alfonso Lopez-Quintana, Jose Ramon March

Objective: To determine whether the increase in plasma levels of C-Reactive Protein (CRP), a non-specific reactant in the acute-phase of systemic inflammation, is associated with clinical severity of peripheral arterial disease (PAD).

Methods and results: This is a cross-sectional study at a referral hospital center of institutional practice in Madrid, Spain. A stratified random sampling was done over a population of 3370 patients with symptomatic PAD from the outpatient vascular laboratory database in 2007 in the order of their clinical severity: the first group of patients with mild chronological clinical severity who did not require surgical revascularization, the second group consisted of patients with moderate clinical severity who had only undergone only one surgical revascularization procedure and the third group consisted of patients who were severely affected and had undergone two or more surgical revascularization procedures of the lower extremities in different areas or needed late re-interventions. The Neyman affixation was used to calculate the sample size with a fixed relative error of 0.1. A homogeneity analysis between groups and a unifactorial analysis of comparison of medians for CRP was done. The groups were homogeneous for age, smoking status, Arterial Hypertension HTA, diabetes mellitus, dyslipemia, homocysteinemia and specific markers of inflammation. In the unifactorial analysis of multiple comparisons of medians according to Scheffé, it was observed that the median values of CRP plasma levels were increased in association with higher clinical severity of PAD (3.81 mg/L [2.14-5.48] vs. 8.33 [4.38-9.19] vs. 12.83 [9.5-14.16]; p < 0.05) as a unique factor of tested ones.

Conclusion: Plasma levels of CRP are associated with not only the presence of atherosclerosis but also with its chronological clinical severity.

目的确定全身炎症急性期的非特异性反应物 C 反应蛋白(CRP)血浆水平的升高是否与外周动脉疾病(PAD)的临床严重程度有关:这是一项在西班牙马德里一家转诊医院中心进行的横断面研究。研究从 2007 年门诊血管实验室数据库中的 3370 名有症状的 PAD 患者中进行了分层随机抽样,按照患者的临床严重程度排序:第一组为轻度慢性临床严重程度患者,他们不需要接受外科血管重建手术;第二组为中度临床严重程度患者,他们只接受过一次外科血管重建手术;第三组为重度患者,他们在不同部位接受过两次或两次以上的下肢外科血管重建手术,或需要后期再次干预。计算样本量时使用了奈曼法,相对误差固定为 0.1。对 CRP 进行了组间同质性分析和中位数比较的单因素分析。各组在年龄、吸烟状况、动脉高血压 HTA、糖尿病、血脂异常、同型半胱氨酸血症和特定炎症指标方面具有同质性。根据 Scheffé 方法对中位数进行的单因素多重比较分析表明,CRP 血浆水平的中位值增加与 PAD 临床严重程度较高有关(3.81 mg/L [2.14-5.48] vs. 8.33 [4.38-9.19] vs. 12.83 [9.5-14.16]; p <0.05),是受试者中的一个独特因素:结论:血浆 CRP 水平不仅与动脉粥样硬化的存在有关,还与动脉粥样硬化的临床严重程度有关。
{"title":"Relationship between the plasma concentration of C-reactive protein and severity of peripheral arterial disease.","authors":"Joaquin De Haro, Francisco Acin, Francisco Jose Medina, Alfonso Lopez-Quintana, Jose Ramon March","doi":"10.4137/cmc.s1062","DOIUrl":"10.4137/cmc.s1062","url":null,"abstract":"<p><strong>Objective: </strong>To determine whether the increase in plasma levels of C-Reactive Protein (CRP), a non-specific reactant in the acute-phase of systemic inflammation, is associated with clinical severity of peripheral arterial disease (PAD).</p><p><strong>Methods and results: </strong>This is a cross-sectional study at a referral hospital center of institutional practice in Madrid, Spain. A stratified random sampling was done over a population of 3370 patients with symptomatic PAD from the outpatient vascular laboratory database in 2007 in the order of their clinical severity: the first group of patients with mild chronological clinical severity who did not require surgical revascularization, the second group consisted of patients with moderate clinical severity who had only undergone only one surgical revascularization procedure and the third group consisted of patients who were severely affected and had undergone two or more surgical revascularization procedures of the lower extremities in different areas or needed late re-interventions. The Neyman affixation was used to calculate the sample size with a fixed relative error of 0.1. A homogeneity analysis between groups and a unifactorial analysis of comparison of medians for CRP was done. The groups were homogeneous for age, smoking status, Arterial Hypertension HTA, diabetes mellitus, dyslipemia, homocysteinemia and specific markers of inflammation. In the unifactorial analysis of multiple comparisons of medians according to Scheffé, it was observed that the median values of CRP plasma levels were increased in association with higher clinical severity of PAD (3.81 mg/L [2.14-5.48] vs. 8.33 [4.38-9.19] vs. 12.83 [9.5-14.16]; p < 0.05) as a unique factor of tested ones.</p><p><strong>Conclusion: </strong>Plasma levels of CRP are associated with not only the presence of atherosclerosis but also with its chronological clinical severity.</p>","PeriodicalId":88450,"journal":{"name":"Clinical medicine. Cardiology","volume":"3 ","pages":"1-7"},"PeriodicalIF":0.0,"publicationDate":"2008-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872580/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29019998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical medicine. Cardiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1